Clinical Trial Update: Low Dose Ruxolitinib in Combination With Methylprednisolone [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for low-dose ruxolitinib combined with methylprednisolone in Phase 1/2 for acute graft-versus-host disease and stem cell transplant compli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Stem Cell Transplant Complications

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)
• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: aGVHD, Stem Cell Transplant Complications | Phase 1, Phase 2 | Status: COMPLETED